Transformation of atrioventricular (AV) canal endocardium into invasive mesenchyme correlates spatially and temporally with the expression of bone morphogenetic protein (BMP)-2 in the AV myocardium. We revealed the presence of mRNA of Type I BMP receptors, BMPR-1A (ALK3), BMPR-1B (ALK6) and ALK2 in chick AV endocardium at stage-14 − , the onset of epithelial to mesenchymal transformation (EMT), by
Introduction
Valvuloseptal morphogenesis of the primitive heart tube into a four-chambered organ requires the formation of the endocardial cushion tissue in two segments of the primary heart tube, the atrioventricular (AV) canal and the conus/truncus outlet (OT) (reviews: Eisenberg and Markwald, 1995; Markwald et al., 1996; Nakajima et al., 2000; Person et al., 2005) . In the AV canal, transformation of endocardial endothelial cells into invasive mesenchymal cells plays a critical role in cushion tissue formation and this transformation correlates spatially and temporally with the expression of bone morphogenetic protein-2 (BMP-2) in the AV myocardium (Lyons et al., 1990; Jones et al., 1991; Yamada et al., 1999; Yamagishi et al., 1999; Somi et al., 2004; Sugi et al., 2004) . BMPs, a subgroup of the transforming growth factor (TGF)-β super-family, are well implicated in embryonic development (Francis-West et al., 1994; Wall and Hogan, 1995; Hogan, 1996) . However, early lethality of conventional BMP-2- (Zhang and Bradley, 1996) , BMPR-1A- (Mishina et al., 1995) or BMPR-II- (Beppu et al., 2000) deficient mice significantly hampered addressing the role of BMPs in AV EMT. Using in vitro culture assays, we were able to show that BMP-2 was sufficient and BMP-signaling was required for AV EMT in mice (Sugi et al., 2004) . More recently, conditional deletion of BMP-2 using the NKx2.5-cre system confirmed that myocardially derived BMP-2 was essential for AV endocardial transformation into cushion mesenchyme in Developmental Biology 306 (2007) 179 -192 www.elsevier.com/locate/ydbio mice Rivera-Feliciano and Tabin, 2006) . BMP-2 was also implicated in AV canal morphogenesis in chick (Yamagishi et al., 1999; Romano and Runyan, 2000) . However, expression of BMP receptors in AV endocardium and the functional roles of these receptors in AV EMT remained to be elucidated.
BMPs exert their biological function by interacting with cell surface receptors. BMP receptors consist of Type-1 and Type-2 receptors and both types of receptors contain intracellular serine/threonine kinase domains, which are required for signal transduction. Type-2 receptors transphosphorylate the glycine-serine-rich domain (GS domain) of Type-1 receptors, which induce activation of the Type-1 receptor and transduce signals (Hogan, 1996; Yamashita et al., 1996; de Caestecker, 2004) . BMP type 1 receptors are classified into subtypes, activin-receptor-like kinase-1, (ALK)-1/TTSR-I, activin Type I receptor, (ACTRI)/ALK2, ALK3/BMPR-1A, and ALK6/BMPR-1B (Hogan, 1996; Yamashita et al., 1996; Yi et al., 2000) . Most of the BMP receptors have ligand binding affinity with other TGFβ super family proteins, i.e. TGFβs and activin (Yamashita et al., 1996; de Caestecker, 2004 ). However, BMPR1-A (ALK3) and BMPR1-B (ALK6) bind specifically with BMP-2 and BMP-4, and bind with BMP-7 at low affinity but do not bind with TGFβs or activin (Dijke et al., 1994; Raftery and Sutherland, 1999; de Caestecker, 2004) .
In this work, we detected transcripts of BMPR-1A (ALK 3), BMPR-1B (ALK 6), and ALK2 in AV endocardial cells at stage-14 − , at the onset of AV EMT by RT-PCR and localized BMPR-1B in endocardium in stage-14 − /15 chick embryos. Because multiple BMP receptors are expressed in the endocardium, we sought to address the role of BMP signaling in the AV endocardium using a dominant-negative approach to circumvent functional redundancies. We over expressed dn-or ca-BMPR-1B using RCAS (avian leukemia virus long terminal repeat with splice acceptor)-based viral constructs to specifically perturb or actively transduce the BMP signaling in chick AV explants and whole-embryo cultures. A significance of the virally supported gene transfer technique is that we can alter the signaling in a spatio-temporally specific manner coincident with AV canal morphogenesis without affecting the growth of other parts of the embryos. Moreover, RCAS virus-infected cells, both in culture and in vivo (ovo), could be visually detected using antibodies to RCAS viral protein to make direct comparison of infected-and non-infected cells in the same biological condition.
Our findings provide evidence that BMP signaling through AV endocardial endothelial cells is required for AV EMT and that the activation of the BMP receptor in endocardial cells promotes AV cushion mesenchymal cell formation in the chick. This work was partially reported in an abstract form (Okagawa et al., 2000) . − and -18 chick embryo hearts. Extracted RNAs were reverse-transcribed and cDNA samples were subjected to PCR to amplify cDNA of BMPR-1A and BMPR-1B. Both BMPR-1A (lanes 2, 4, and 6) and BMPR-1B (lanes 3, 5, and 7) transcripts were detected at stage-14 − (lanes 2 and 3) and -18 (lanes 4 and 5). For the PCR controls (lanes 6 and 7), reverse transcriptase was omitted from a reaction performed on RNA from the stage-18 chick embryo heart. The PCR products were separated on a 1.1% agarose gel. Lanes 1 and 8 contained 100-bp and 1-kbp ladder size markers, respectively. 
Materials and methods

Chick embryos
Viral-free fertilized eggs of White Leghorn (Gallus gallus domesticus) chicken were purchased from SPAFAS (Preston, CN) and incubated in a humid atmosphere at 37.5°C. Stages of embryonic development were determined by using the criteria of Hamburger and Hamilton (1951) .
Detection of Type I BMP receptor expression from chick heart by RT-PCR RT-PCR analysis of BMPR-1A, BMPR-1B, and ALK2 was performed based on the methods described previously (Sugi and Markwald, 2003) .
Briefly, total RNA was isolated and purified from chick hearts from Hamburger and Hamilton (1951) stage-14 − and -18 chick embryos and stage-14 − endocardium using the RNAzol method (Chomczynski and Sacchi, 1987; TEL-TEST, Inc.) . AV endocardium was prepared by culturing stage-14 − AV canal, facing endocardial-side down to the fibronectin (20 μg/ml, Sigma)-coated culture wells and by removing myocardium in 4 h. Complementary DNA was prepared by using oligo-dT (Promega) primed M-MLV reverse transcriptase (Promega). The cDNA was amplified using Thermus aquaticus (Taq) DNA polymerase (Promega). Primers (Invitrogen) for whole hearts were designed for BMPR-1A (forward, 5′-CAAGCACTATTGTAAGT-CAATG-3′, reverse, 5′-TCAAATCTTTACATCTTGTGAT-3′), BMPR-1B (forward, 5′-TGCTACTTCAGGTATAAGCGGC-3′, reverse 5′-TTAGAGCT-TAATGTCCTGCGAC-3′). Primers for stage-14 − AV endocardium were designed for BMPR-1A (forward, 5′-CTGAGAGTTGAGCGATTG-3′, reverse, 5′-CAGCCAGAAGCAAGTGTTGG-3′), BMPR-1B (forward, 5′- GGAGAGCAGAAAAGAAGATAGTGAGG-3′, reverse, 5′-TGGTGTGGAA-TAGGAGTGTCC-3′) and ALK2 (forward, 5′-CTGTGTTGGGGTCACTG-3′, reverse, 5′-TGGAAGCAGCCTTTCTGG-3′). Sequence information was from GenBank and accession numbers are L49204 for BMPR-1A, D13432 for BMPR-1B, and U38622 for ALK2, respectively. That the predicted PCR products were not amplified from genomic DNA was verified by treating samples with RNase-free DNase-1 (Promega) before RT. As a negative control, the RT step was omitted. The PCR products were verified by thermal cycle sequencing using Taq DNA polymerase and fluorescent dye-labeled terminations (Medical University of South Carolina, Biotechnology Resource Laboratory).
In situ hybridization
Digoxigenin-labeled, single-stranded RNA was generated using the DIG RNA labeling kit (Roche) according to manufacturer's instructions. A chick BMPR1-B cDNA cloned into pBluescript II SK (+) (kindly provided by Dr. T. Nohno, Okayama, Japan) was linearized using EcoRI for the sense probe or BamHI for the antisense probe. T3 RNA polymerase or T7 RNA polymerase was used to construct the sense or antisense probe, respectively.
For whole-mount preparation, chick embryos from stages 8 to 18 were collected and fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) and processed for whole mount in situ hybridization. After the treatment of proteinase K (Roche) and rinsing in PBS-Tween 20, samples were treated with hybridization buffer for prehybridization for 2-4 h then hybridized with a digoxigenin-labeled probe (0.2 μg/ml) in the hybridization buffer at 65°C overnight. After rinsing, samples were treated for immunohistochemical detection of digoxigenin by using alkaline phosphatase-conjugated sheep antidigoxigenin Fab fragment (Roche) and signals were detected by nitroblue tetrazolium chloride (NBT)/5-bromo-4-chloro-3-indolyl phosphate, toluidine salt (BCIP) (Roche).
In situ hybridization of tissue sections was performed as previously described (Somi et al., 2004) with the following modifications. Paraformaldehyde-fixed stage-10 to -18 chick embryos were embedded in paraffin and 10-μm sections were cut and processed through 20 μg/ml proteinase K (Ambion)/PBS Fig. 3 . Quantitative evaluation of invasive mesenchymal cell formation from AV endocardial monolayer treated with M199 alone, BMP-2, BMP-2 + dnBMPR-1B, BMP-2 + caBMPR-1B or BMP-2 + noggin. BMP-2 supported mesenchymal cell formation was significantly inhibited in noggin-(*p < 0.001 by Student's t-test) or dnBMPR-1B-(*p < 0.001 by Student's t-test) treated explants and was enhanced in caBMPR-1B-(**p < 0.03 by Student's t-test) treated explants. Number of explants evaluated for each treatment: 24 for M199 alone, 16 for BMP-2, 20 for BMP-2 + dnBMPR-1B, 21 for BMP-2 + caBMPR-1B and 8 for noggin. N = number of areas counted in each explant. Fig. 4 . AV endocardial monolayer treated with BMP-2 + dnBMPR-1B, BMP-2 + caBMPR-1B or M199 alone were double immunostained with a RCAS viral marker, AMV3c2 (A, D, and G) and a mesenchymal marker, anti-α-SMA (B, E, and H) or anti-TGFβ3 (C, F, and I). Panels A and B, D and E, G and H depict the same area of the explants. Panels C, F, and I depict different areas of the same explants. These pictures indicate that dnBMPR-1B-infected cells tend to stay on the surface of the gel as α-SMA-negative TGFβ3-negative endocardial epithelial cells (A-C), whereas, caBMPR-1B-infected cells tend to become invasive SMA-positive, TGFβ3-positive mesenchymal cells (D-F). Panels G-I are explants not infected with the virus but cultured with M199 alone, which shows negative staining for AMV3c2, anti-α-SMA and anti-TGFβ3. Scale bar = 100 μm.
for 5-7 min at room temperature. Hybridization was performed using 0.2 μg/ml Dig-labeled riboprobe at 70°C overnight. Color reactions using NBT/BCIP were allowed to develop for 48-72 h at room temperature.
Generation and propagation of retrovirus
Two mutant constructs of chick BMPR-1B cloned into the replicationcompetent avian retroviral vector RCAS-(A) (Hughes et al., 1987) were kindly provided by Dr. L. Niswander (Howard Hughes Medical Institute and University of Colorado Health Sciences Center-Fitzsimmons Campus Denver, CO). The dominant-negative form (dnBMPR-1B) blocks BMP signaling pathways by a single amino acid substitution (Lys-231 to Arg) within the adenosine triphosphate binding site in the kinase domain. Because dnBMPR-1B lacks the activity of an intracellular kinase domain, dnBMPR-1B expressed at the cell surface can bind BMPs but does not transmit signals. The constitutively active form (caBMPR-1B) has a single amino acid substitution (Gln-203 to Asp) within the GS activation domain. caBMPR-1B is activated constitutively and transmits signals without BMP binding. dnBMPR-1B and caBMPR-1B viruses were previously constructed and blocked and activated BMP signaling, respectively, in avian embryonic tissue cultures (Zou and Niswander, 1996; Zou et al., 1997) .
Primary fibroblasts cells were collected from day-10 chick embryos and transfected with retroviral constructs with FuGENE 6-transfection reagent (Roche). Supernatant from the transfected cultures was collected and concentrated by ultracentrifugation. Concentrated virus was resuspended in M199 (Invitrogen) and stored at −80°C. The viral titer was measured with immunohistochemical detection of viral protein p19 by monoclonal antibody, AMV3c2 (Developmental Studies Hybridoma Bank) using virus-infected fibroblast culture. A viral titer (2-5 × 10 9-10 active virion/ml) was constantly achieved after ultracentrifugation of the viral supernatant.
AV explant culture
The culturing procedure was described previously (Bernanke and Markwald, 1982; Runyan and Markwald, 1983; Ramsdell and Markwald, 1997) . Briefly, AV explants from stage-14 − chick embryo hearts were placed on the hydrated collagen gels (rat tail tendon collagen, 1.0 mg/ml, Collaborative Research), equilibrated in medium (M 199, Invitrogen) , supplemented with 1% chick serum (Sigma) and ITS (5 μg/ml insulin, 5 μg/ml transferrin, and 5 ng/ml selenium, Collaborative Research), and antibiotics (100 units/ml penicillin and 100 μg/ml streptomycin, Invitrogen). For AV endocardial endothelial culture, myocardium was removed 4 h after placement of the explants on the collagen gel. Recombinant human noggin (kindly provided by Regeneron Pharmaceuticals, Inc., NY; final concentration, 500 ng/ml), BMP-2 (kindly provided by Genetics Institute, MA; final concentration, 200 ng/ml), and dnBMPR-1B or caBMPR-1B-RCAS virus (final concentration, 1.5 × 10 8 virion/ml) were added alone or in combination with BMP-2 to the culture 4 h after the placement of the explants onto the gel. For some experiments, endocardium was co-cultured with associated myocardium and was infected with dnBMPR-1B or caBMPR-1B, or treated with noggin. Cultures were observed daily under an inverted microscope (Olympus, IMT-2). For the index of mesenchymal cell formation, cells on the surface and at − 80-μm deep from the surface of the collagen gel were counted after 48 h of culture. caBMPR-1B (E and F) or noggin (500 ng/ml) (G and H) for 48 h. Explants treated with caBMPR-1B formed more invasive mesenchymal cells (E and F) than control explants cultured in M199 alone (A and B). Conversely, similar to the effect of noggin (G and H), when cultured with dnBMPR-1B, fewer cells invaded into the collagen gel (C and D). m, myocardium. arrows, invasive mesenchymal cells. Scale bar = 100 μm.
Immunostaining of cultured explants
Cultured explants were double-immunostained with a combination of AMV3c2 and anti-α-SMA (Sigma), anti-TGFβ3 (Santa Cruz) and anti-α-SMA, or AMV3c2 and anti-TGFβ3 depending on the experimental necessity. AMV3c2 recognizes RCAS viral protein, and α-SMA has been used as a marker for AV cushion mesenchymal cell formation in the chick (Nakajima et al., 1997) . The specificity of the anti-TGFβ3 was previously tested by immunopreabsorption using chick AV cushion tissues (Ramsdell and Markwald, 1997) . After a 48-h culture, explants were fixed with 4% paraformaldehyde and subsequently rinsed with 1.5% Tween/PBS (PBST), blocked with 10% normal goat serum (ICN) and incubated with primary antibody, AMV3c2. Immune complexes were detected with FITC-conjugated goat anti-mouse IgG (ICN). For double-immunostaining with anti-TGFβ3 and anti-α-SMA, explants were fixed with 100% methanol at −20°C and treated for immunostaining as described above. For double-immunostaining with anti-TGFβ3 and AMV3c2, samples were processed for AMV3c2 immunostaining as described above and stained with anti-TGFβ3. Immunostained samples were observed under a confocal microscope, Bio-Rad MRC-1000 Laser Scanning Confocal Imaging System equipped with a Zeiss Axioskop.
TGFβ3 immunointensity in cells
Detection of immunointensity was described previously (Sugi et al., 2004) . Briefly, original photographs were taken under a laser confocal microscope (BioRad MCR-1000) equipped with a Zeiss Axioskop. For each sample, the same condenser iris opening (4.0) and 30% laser was applied. TGFβ3 immunointensity was evaluated by measuring the intensity of TGFβ3 immunofluorescence of the cells in the photograph using the computer software, Adobe Photoshop 5.5 (Adobe System, Inc.). AMV3c2 positive endocardial epithelial cells or mesenchymal cells were analyzed to obtain the average intensity of TGFβ3 immunofluorescence for each viral treatment. The average fluorescent intensity of endocardial epithelial cells cultured with M199 alone was used as a control for TGFβ3 immunointensity.
Microinjection
Fertilized chicken eggs were incubated in a humid atmosphere at 37.5°C, windowed, and carefully staged. A volume (1-5 nl) of dnBMPR-1B or caBMPR-1B-virus solution (viral titer, 2-5 × 10 9 active virion/ml) containing Polybrene (100 μg/ml) was pressure injected into cardiac jelly near the endocardial side of AV canal in stage-13 chick embryos in ovo with a microinjector apparatus, the Picospritzer II pressure system (Parker, NJ), which was equipped with three-dimensional manipulators, MMN-1 and MMO-220ND (Narishige, Japan), and one-dimensional micromanipulator, MMO-220 (Narishige, Japan). Eggs were resealed and incubated for an additional two days. Embryos were fixed with 4% paraformaldehyde and processed for AMV3c2-immunostaining followed by FITC-conjugated secondary antibody detection. Virally infected cells in the AV canal were detected under a confocal microscope (Bio-Rad MRC-1000, Laser Scanning Confocal Imaging System equipped with a Zeiss Axioskop). Some embryos were embedded in paraffin (Paraplast X-TRA) and processed for sectioning at 6 μm.
Results
Expression of Type I BMP receptors by chick AV endocardium
RT-PCR analysis revealed mRNA-expression of BMPR-1A and BMPR-1B from stage-14 − and -18 chick embryonic hearts (Fig. 1A) . BMPR-1A, BMPR-1B, and ALK2 were detected from cultured stage-14 − AV endocardium (Fig. 1E ). BMPR-1B mRNA was localized by whole-mount in situ hybridization in stage-14 chick embryos. BMPR-1B mRNA was expressed in endocardium (arrows in Figs. 1C, D) and somites (Fig. 1C) . BMPR-1B was also expressed in branchial arches and the neuroepithelial wall of the ventricle in the brain (not shown). Although endocardial expression was low, its expression was consistent with the RT-PCR data shown above. Restriction of BMPR-1B to the AV or OT region was not clearly detected (Figs. 1C, D) . Section in situ hybridization also revealed BMPR-1B expression in the endocardium. However, there was no clear restriction of the BMPR-1B to the cushion forming segments of in the heart (not shown).
AV endocardial endothelium was cultured on collagen gels to assess the effect of dnBMPR-1B, caBMPR-1B, or noggin under treatment of BMP-2 AV endocardial epithelial monolayers were explanted from stage-14 − chick embryos. When AV endocardial monolayers were cultured in M199 alone in the absence of myocardium, epithelial monolayers extended on the surface of the collagen gels ( Fig. 2A) but invasive mesenchymal cells were not detected (Figs. 2B and 3) as previously reported (Krug et al., 1985; Mjaatvedt et al., 1987; Nakajima et al., 1994; Ramsdell and Markwald, 1997) . In contrast, when endocardial epithelial monolayers were cultured with BMP-2 in M199, the explants formed invasive mesenchymal cells within 48 h (Figs. 2D and  3 ). BMP-2-supported mesenchymal cell formation was largely inhibited by adding dnBMPR-1B virus to the culture (Figs. 2E, F and 3) similar to the effect of noggin, an antagonist to BMP-2/4 (Zimmerman et al., 1996) (Figs. 2I, J and 3) . Conversely, when AV endocardial epithelial monolayers were treated with BMP-2 + caBMPR-1B they exhibited a larger number of invasive mesenchymal cells within the collagen gel (Figs. 2H and 3) .
Cultured AV endothelial monolayers were further evaluated for the expression of mesenchymal markers. The explants were double immunostained with a virus marker, AMV3c2 and Fig. 6 . Quantitative evaluation of invasive mesenchymal cell formation from AV endocardial/myocardial co-culture treated with dnBMPR-1B, caBMPR-1B, or noggin. Mesenchymal cell formation was significantly inhibited in noggin-or dnBMPR-1B-treated explants and enhanced in caBMPR-1B-treated explants (*p < 0.005 by Student's t-test). Number of explants tested for each treatment: 15 for M199-treated, 19 for dnBMPR-1B-treated, 22 for caBMPR-1B-treated and 11 for Noggin-treated. N = number of areas counted in each explant. mesenchymal cell markers, anti-α-SMA and anti-TGFβ3. TGFβ3 has been used as a chick cardiac cushion mesenchymal cell marker (Nakajima et al., 1997) . In the AV endocardial monolayers treated with BMP-2 + dnBMPR-1B, most of the endocardial epithelial cells were positive for AMV3c2 (Fig. 4A) but not with α-SMA (Fig. 4B) or TGFβ3 (Fig. 4C) . Whereas many mesenchymal cells stained with AMV3c2 expressed α-SMA and TGFβ-3 in AV endocardial explants treated with BMP-2 + caBMPR-1B (Figs. 4D-F) . These results indicated that dnBMPR-1B-infected cells remained on the surface of the gel as α-SMA-negative endocardial epithelial cells, whereas, caBMPR-1B-infected cells became α-SMA-positive, TGFβ3-positive mesenchymal cells. Taken together, our findings indicated that dominant-negative BMPR-1B perturbed/inhibited BMP-2-supported AV EMT, whereas active BMPR-1B promoted EMT in the chick AV endocardial monolayer.
AV endocardial epithelium was co-cultured with myocardium on collagen gels to assess the effect of dnBMPR-1B, caBMPR-1B, or noggin AV endocardium from stage-14 − chick embryos was cocultured with associated myocardium on the collagen gels. After 48 h in co-culture with M199 alone, endothelial monolayers extended on the surface of the collagen gels (Fig.  5A ) and invasive mesenchymal cells were formed (Figs. 5B Fig. 7 . AV endocardial/myocardial co-culture treated with dnBMPR-1B or caBMPR-1B were double immunostained with a RCAS viral marker, AMV3c2 (A, C, E, and G) and a mesenchymal marker, anti-α-SMA (B, D, F, and H). dnBMPR-1B-infected cells tended to stay on the surface of the gel as α-SMA-negative endocardial epithelial cells (arrows in panels A and B). Whereas many dnBMPR-1B-non-infected cells transformed and expressed α-SMA (arrowheads in panels C and D). caBMPR-1B-infected cells tended to become invasive SMA-positive mesenchymal cells (arrows in panels G and H), while caBMPR-1B-non-infected cells remained as α-SMA-negative epithelial cells (arrowheads in panels E and F). Scale bar = 100 μm. and 6) as previously reported (Krug et al., 1985; Nakajima et al., 1994; Mjaatvedt et al., 1987; Ramsdell and Markwald, 1997) . When explants were treated with dnBMPR-1B, endocardial monolayers also grew on the surface of the collagen gels (Fig. 5C ) but significantly fewer invasive mesenchymal cells were formed (Figs. 5D and 6 ) similar to the effect of noggin treatments (Figs. 5G, H, and 6 ). In contrast, AV explants treated with caBMPR-1B formed more invasive mesenchymal cells (Figs. 5F and 6) than control explants cultured in M199 alone (Fig. 5B) .
To evaluate mesenchymal marker expression in AV endocardial explants co-cultured with myocardium, the explants were double immunostained with AMV3c2, a virus marker, and anti-α-SMA, a mesenchymal cell marker. Regardless of which types of viruses infected the cells, when mesenchymal cells were formed, α-SMA was detected in all mesenchymal cells (Figs. 7D, H) but not in endocardial epithelial cells (Figs. 7B, F) . Many endocardial epithelial cells in explants treated with dnBMPR-1B were AMV3c2-positive (Figs. 7A and 8) whereas significantly fewer mesenchymal cells were AMV3c2-positive, indicating that the majority of dnBMPR-1B-infected endocardial cells remained epithelial and stayed on the surface of the collagen gels (Figs. 7C and 8 ). Fewer number of endocardial epithelial cells in the explants treated with caBMPR-1B showed AMV3c2 staining (Figs. 7E and 8) , whereas larger numbers of mesenchymal cells exhibited AMV3c2 staining (Figs. 7G and 8 ), indicating that a majority of caBMPR-1B virus-infected cells transformed into mesenchymal cells and invaded into collagen gels.
Viruses can infect cells at the surface of the explants directly exposed to the viral solution but cannot penetrate deeper into the tissue mass. Thus, dnBMPR-1B and caBMPR-1B viruses do not infect as many endocardial epithelial cells in co-cultured explants as seen in endocardial monolayer cultures. Therefore, to assess the differences in the effects of caBMPR-1B and dnBMPR-1B infection in mesenchymal cell formation, the infection ratio of the invasive mesenchymal cells was compared in the caBMPR-1B-infected and dnBMPR-1B-infected AV explants co-cultured with myocardium. As seen in Fig. 9 , there was a statistically significant tendency for dnBMPR-1B-infected cells to remain on the surface of the gel as α-SMAnegative endocardial epithelial cells, while caBMPR-1B-infected cells transformed into α-SMA-positive invasive mesenchymal cells (also see scheme in Fig. 15 ). Although viruses can infect surface of the myocardium in co-cultured explants, it is less likely that the effects seen with dn-and caBMPR-1B virus-infection were largely affected by viral infection of the myocardium because we were able to immunohistochemically identify AMV3c2-positive cells and directly compared virus-infected endocardial cells with noninfected cells in the same explant.
In AV endocardial monolayer explants TGFβ3 was expressed in mesenchymal cells induced by BMP-2 or BMP-2 + caBMPR-1B but not expressed in endocardial epithelial cells treated with BMP-2 + dnBMPR-1B or M199 alone When AV explants were cultured with dnBMPR-1B + BMP-2 in the absence of myocardium, an endocardial monolayer grew on the surface of the collagen gels but few invasive mesenchymal cells were formed. Double immunolabeling of anti-TGFβ3 and anti-α-SMA showed that endocardial epithelial cells expressed little TGFβ3 (Fig. 10A ) or α-SMA (Fig. 10B) . Whereas, when explant was cultured with BMP-2 alone in the absence of myocardium, endocardial epithelial cells did not express TGFβ3 or α-SMA (asterisks in Figs. 10E, F) but many mesenchymal cells expressed TGFβ3 and α-SMA (arrows in Fig. 8 . Quantitative evaluation of invasive mesenchymal cell formation in AV endocardial/myocardial co-culture treated with dnBMPR-1B or caBMPR-1B (Fig. 7 ). An infection ratio (%) was calculated from the AMV3c2-positive cell number/total cell number of surface endocardial endothelial cells (Endo) or mesenchymal cells (Mes) in dnBMPR-1B-or caBMPR-1B-treated explants, respectively. For endocardial endothelial cells, dnBMPR-1B-infected cells occupied a significantly larger portion than caBMPR-1B-infected cells (*p < 0.002 by Student's t-test). Conversely, for mesenchymal cells, caBMPR-1B-infected cells occupied a significantly larger portion than dnBMPR-1B-infected cells (*p < 0.002 by Student's t-test). N = number of the areas counted. Fig. 9 . Quantitative evaluation and schematic illustration of mesenchymal cell formation in endocardial/myocardial co-culture treated with dnBMPR-1B or caBMPR-1B. dnBMPR-1B-treated explants formed significantly fewer mesenchymal cells in comparison with caBMPR-1B-treated explants. If virusinfected (AMV3c2-positive) cells were specifically compared, the difference between dnBMPR-1B-infected explants and caBMPR-1B-infected explants was more prominent in mesenchymal cell formation. This diagram shows that dnBMPR-1B significantly reduced mesenchymal cell formation from AV endocardial/myocardial co-culture. N = number of explants.
Figs. 10E, F). When cultured with caBMPR-1B + BMP-2, many invasive mesenchymal cells were formed and expressed both TGFβ3 (Fig. 10C ) and α-SMA (Fig. 10D) . When explants were cultured with control medium M199 alone, only endocardial monolayers were formed and little, if any, expression of TGFβ3 (Fig. 10G ) and α-SMA was detected (Fig. 10H) .
In AV endocardial/myocardial co-culture, TGFβ3 expression was suppressed in dnBMPR-1B-infected endocardial cells but enhanced in caBMPR-1B-infected endocardial epithelial cells To address the relationship between BMP signaling and other known endocardially derived mesenchymal cell inducers, such as TGFβs (Potts and Runyan, 1989; Potts et al., 1991; Nakajima et al., 1994 Nakajima et al., , 1998 Ramsdell and Markwald, 1997) in AV cushion formation, AVexplants co-cultured with myocardium and infected with dnBMPR-1B or caBMPR-1B were double immunostained with AMV3c2, a virus marker, and anti-TGFβ3. dnBMPR-1B-infected cells tended to stay on the surface of the gel as TGFβ3-negative endocardial epithelial cells (arrowheads in Figs. 11A-C and 12) . Conversely, caBMPR-1B-infected cells tended to become TGFβ3-positive endocardial epithelial cells or invasive TGFβ3-positive mesenchymal cells (arrows in Figs.  11D-F and 12) . Some of the endocardial cells infected with caBMPR-1B appeared to express TGFβ3 when they were on the surface of the gels, before they transformed into invasive mesenchymal cells (arrowheads in Figs. 11D-F ). There were statistically significant differences in TGFβ3 immunointensity between dnBMPR-1B-infected and caBMPR-1B-infected endocardial endothelial cells (Fig. 12) . However, when dnBMPR-1B infection did not completely block TGFβ3 expression, cells appeared to transform into mesenchymal cells and express TGFβ3 (arrows in Figs. 11A-C) . Fig. 10 . AV endocardial monolayer treated with BMP-2 + dnBMPR-1B, BMP-2 + caBMPR-1B, BMP-2 or M199 alone were double immunostained with anti-TGFβ3 (A, C, E, and G) and a mesenchymal marker, anti-α-SMA (B, D, F, and H). Endocardial epithelial cells in the explants treated with BMP-2 + dnBMPR-1B did not express TGFβ3 (A) or α-SMA (B). Whereas, when explants were cultured with caBMPR-1B + BMP-2, many invasive mesenchymal cells were formed and expressed both TGFβ3 (C) and α-SMA (D), similar to the explants treated with BMP-2 alone (E and F). When explants were cultured with M199 alone, TGFβ3-negative, α-SMA-negative endothelial cells, but not invasive mesenchymal cells were formed. Asterisks indicate TGFβ3-negative, α-SMA-negative endothelial cells. Arrows indicate mesenchymal cells which express TGFβ3 and α-SMA. Scale bar = 100 μm.
Microinjection study of dnBMPR-1B and caBMPR-1B into AV cushion tissue
The dnBMPR-1B or caBMPR-1B virus was microinjected into cardiac jelly near the endocardial side of the AV canal in chick embryos in ovo at stage-13 when endocardial cells had not yet transformed. Eggs were incubated for an additional two days. Virus-infected cells were detected by a viral marker, AMV3c2 immunohistochemistry, and confocal microscopy. The majority of the cells that had been infected with dnBMPR-1B remained at or near the luminal surface of the AV cushion as epithelial cells (Figs. 13A-C and 14) , whereas most of the caBMPR-1B-infected cells transformed into mesenchymal cells and invaded deeply into AV cushion (Figs. 13D-F and 14) . It is important to note that, in some representative cases, while cushion mesenchyme was formed, all of the AMV3c2-positive dnBMPR-1B-infected cells remained as endocardial epithelial cells (Fig. 13) .
Discussion
A dominant-negative approach can circumvent functional redundancies among Type I BMP receptors in chick AV EMT Our present study indicated that dnBMPR-1B infection or noggin treatment of AV endocardium significantly reduced EMT whereas caBMPR-1B infection enhanced EMT from AV endocardium in the presence of BMP-2 or associated AV myocardium in chick AV culture (Figs. 2, 5 and 15) . Moreover, our microinjection study revealed that dnBMPR-1B virusinfected cells remained in the endocardial epithelium, whereas caBMPR-1B-infected cells invaded deeper into the cushion as mesenchyme in vivo (ovo) (Fig. 13) . These data provided evidence that BMP signaling through endocardial endothelial cells was required in AV EMT and active BMPR-1B in the endocardial cells could induce AV EMT. However, our data do not exclude the possibilities that other BMP receptors in the endocardium are involved in BMP-supported AV EMT, since dominantly expressed mutant BMPR-1B can block signal transduction through any probable BMP receptor. For example, the chick activin type I receptor (ALK2) was implicated in AV mesenchymal cell formation/migration by the study in which neutralizing antibodies to chALK2 were used in chick AV explants (Lai et al., 2000) . Furthermore, active ALK2 was reported to induce ventricular endocardial cells to undergo EMT in the chick (Desgrosellier et al., 2005) .
More recently, functional redundancies among endocardially expressed type I BMP receptors have been suggested by the studies in which ALK3 (BMPR-1A) or ALK2 was conditionally deleted from endothelium in mice Wang et al., 2005; Park et al., 2006; Song et al., 2007) . ALK2 can bind other TGFβ superfamily, TGFβs and Activin in addition to BMPs; however ALK3 transmits BMP signaling exclusively (de Caestecker, 2004) . Regardless of the differences in ligand specificities, mutant mice with ALK2 and ALK3 conditional ablation from the endothelial cells displayed defects in AV septa and valves, which appeared to result from a failure of endocardial EMT. Although ALK3 conditional deletion from the endothelium produced a severe deficiency, neither ALK2 nor ALK3 conditional deletion showed complete disruption of EMT, despite the fact that the BMP-2 conditional deletion from the myocardium completely disrupted AV EMT Rivera-Feliciano and Tabin, 2006) . In fact, one-third of the ALK3 conditional deletion mutants were reported to form Fig. 11 . AV endocardial/myocardial co-culture treated with dnBMPR-1B or caBMPR-1B was double immunostained with a RCAS viral marker, AMV3c2 (A and D) and anti-TGFβ3 (B and E). Panels C and F are merged images of panels A and B, and panels D and E, respectively. The majority of dnBMPR-1B-infected endocardial cells remained as TGFβ3-negative epithelial cells (arrowheads in panels A-C). Only a few dnBMPR-1B-infected endocardial cells became mesenchymal and expressed TGFβ3 (arrows in panels A-C). In contrast, the majority of caBMPR-1B-infected cells became TGFβ3-positive mesenchymal cells (arrows in panels D-F).
Note that a few caBMPR-1B-infected cells remained as epithelial cells but expressed TGFβ3 (arrowheads in panels D-F). Scale bar = 100 μm.
rather normal AV cushion mesenchyme . This could result from variability of cre activity; however, it is possible that the Type I BMP receptor in the endocardium have functional redundancies for AV EMT. This view is consistent with the findings that BMPR-1B is required for chondrogenesis in the limb (Baur et al., 2000; Yi et al., 2000) , where BMPR-1B is the only Type I BMP receptor that transmits BMP signaling in chondrocytes (Abe, 2006) but not for endocardial EMT in the cardiac AV cushion, where multiple BMP receptors are expressed in the endocardial cells. In the present study, dnBMPR-1B infection of endocardium disrupted AV EMT both in the AV explant cultures in vitro and whole-embryo cultures in vivo (ovo). The discrepancy between BMPR-1B knockout data in the mouse and our data from dnBMPR-1B-virus infection in the chick may reflect the functional difference in endocardial BMP receptors between the two species. Nevertheless, the significance of our dominant-negative approach is that it does effectively demonstrate unequivocally the necessity for BMP signaling in AV endocardial cells during AV cushion tissue formation.
TGFβ expression in AV endocardium can be regulated by BMP signaling
TGFβs (Potts and Runyan, 1989; Potts et al., 1991; Nakajima et al., 1994 Nakajima et al., , 1998 Ramsdell and Markwald, 1997; Boyer et al., 1999a; Camenisch et al., 2002) and their receptors (Brown et al., 1996 (Brown et al., , 1999 Boyer et al., 1999b; Lai et al., 2000; Boyer and Runyan, 2001; Desgrosellier et al., 2005) are welldocumented factors implicated in AV cushion mesenchymal cell formation and migration in the chick. AV endocardial epithelial cells in the chick, upon activation by myocardial signaling, appear to express TGFβ3 as part of an in vivo autocrine mechanism for regulating and sustaining the transformation from endocardial to mesenchymal phenotype (Nakajima et al., 1994 (Nakajima et al., , 1998 Ramsdell and Markwald, 1997) . While upregulation of TGFβ3 in the endocardial endothelial cells is critical for Fig. 12 . Quantitative evaluation of AMV3c2 and anti-TGFβ3 double immunostained AV endocardial/myocardial co-culture treated with dnBMPR-1B or caBMPR-1B (Fig. 11) . The data represent the average of TGFβ3 immunostaining intensity from multiple AMV3c2 positive endocardial epithelial cells or mesenchymal cells. The average immunointensity of endocardial epithelial cells in the explants cultured with M199 alone was determined as 100% intensity as control. Immunointensity of dnBMPR-1B infected endocardial epithelial cells was weaker than control (*p < 0.04 by Student's t-test), whereas, immunointensity of caBMPR-1B infected endocardial epithelial cells was stronger than control (**p < 0.0001 by Student's t-test). There was no significant difference in TGFβ3 immunointensity of mesenchymal cells within explants treated with dnBMPR-1B, caBMPR-1B or M199 alone. Number of the explants evaluated for each treatment: 15 for dnBMPR-1B, 13 for caBMPR-1B and 5 for M199 alone. N = number of cells evaluated for immunointensity. Fig. 13 . Microinjection study of dnBMPR-1B and caBMPR-1B into AV cushion tissue. dnBMPR-1B (A-C) or caBMPR-1B (D-F) virus was microinjected into cardiac jelly near the endocardial side of AV canal in chick embryos at stage-13 when endocardial cells had not transformed yet in ovo. Eggs were resealed and incubated for an additional two days. Virus-infected cells (green) were detected by AMV3c2 immunohistochemistry and confocal microscopy (A-E). Panels B and E represent higher power views of panels A and D respectively. Panels C and F are 5-μm sections of the AV canal of chick embryos and represent a typical case after virus microinjection. The majority of dnBMPR-1B-infected cells stayed at or near the luminal surface of the AV cushion as epithelial cells (arrows in panels A-C), whereas most of caBMPR-1B-infected cells transformed into mesenchymal cells and invaded deeper into AV cushion (arrows in panels D-F). The green color in the myocardium in panels A and D is autofluorescence caused by stacking images by confocal microscopy. In panel C (a representative section of AV canal from a dnBMPR-1B-treated embryo), most of the endocardial epithelial cells are AMV3c2-positive, whereas many AV cushion mesenchymal cells are AMV3c2-negative. Since 100% of virus infection cannot be achieved, these viral marker-negative mesenchymal cells are presumably endocardially derived cells that escaped from virus infection or cells which have different origins. a, atrium; v, ventricle; av, atrioventricular canal; o, outflow tract; e, endocardial epithelial cell; m, myocardium. Scale bar in panel A = 100 μm for (A and D). Scale bar in panel B = 100 μm for (B, E, C, and F).
AV EMT in the chick, the factor from the AV myocardium that regulates TGFβ3 expression in AV endocardial cells has not been determined.
Therefore, in the present study, we sought to determine the interactions between BMP signaling and endocardially expressed TGFβ3 in AV EMT. Data from our in vitro culture assays indicated that dnBMPR-1B infection significantly reduced TGFβ3 expression in AV endocardial endothelial cells, whereas caBMPR-1B-infection enhanced TGFβ3-expression even if caBMPR-1B-infected endocardial cells remained on the surface of the collagen gels in culture in the presence of AV myocardium or BMP-2 (Figs. 11 and 12) . Thus, activation of BMPR appeared to correlate with an upregulation of TGFβ3 expression in endocardial endothelial cells, which supports the idea that BMP ligands secreted by the myocardium regulate TGFβ3-expression in the endocardial cells via BMP pathways in AV endocardial cells during EMT. Secretion of TGFβ3 in the endocardial cells, in turn, would enhance AV endocardial EMT and migration of the endocardial cells as described (Nakajima et al., 1994 (Nakajima et al., , 1998 Ramsdell and Markwald, 1997) . Our previous report (Sugi et al., 2004 ) also indicated that BMP-2 induced TGFβ2 expression in AV endocardial cells in mouse AV explant culture, in which TGFβ2 appears to be an endocardial activation marker as reported by Camenisch et al. (2002) . Our results are consistent with the recent mouse data obtained by the conditional deletion of BMP-2 using the Nkx2.5-cre system which displays defects in AV endocardial EMT along with downregulation of TGFβ2 in the AV endocardium . Although BMP signaling in the myocardium can also regulate myocardial TGFβ2 expression as evident in the Alk3 conditional knockout (Gaussin et al., 2002 (Gaussin et al., , 2005 , it is clear that interactions of BMP signaling and TGFβ transcriptional regulation in the endocardial cells during AV EMT appear to be critical for completion of EMT and remain to be elucidated.
BMP signaling through AV endocardial cells is essential for activation of AV endocardial cells in the chick
Although some cushion mesenchyme is formed in TGFβ2 knockout mice (Sanford et al., 1997; Bartram et al., 2001) , TGFβ2 is highly expressed in AV myocardium at the onset of AV EMT in mice and TGFβ2, but not TGFβ3, appears to be required for AV EMT in mouse culture assays (Camenisch et al., 2002) . However, chick TGFβ2 expression is not restricted to Fig. 14. Quantitative evaluation of mesenchymal cell formation in the AV canal microinjected with dnBMPR-1B or caBMPR-1B virus (Fig. 13 ). Embryos were scored positive in mesenchymal cell formation when AMV3c2-positive cells were found in cushion mesenchyme but were scored negative when AMV3c2-positive cells were found only in endocardial epithelium. These results indicate a tendency of dnBMPR-1B-infected cells to remain as endocardial epithelial cells whereas caBMPR-1B-infected cells transform into mesenchymal cells. N = number of embryos evaluated. Fig. 15 . Inhibition and enhancement of mesenchymal cell formation by dnBMPR-1B or caBMPR-1B was schematically illustrated. Since viral infection cannot be 100% in co-cultured explants, non-infected cells can transform into mesenchymal cells regardless of viral treatment. However, the total amount of mesenchymal cell formation is affected by the types of the virus (dn-vs. ca-BMPR-1B) infected the endocardial cells.
AV myocardium but expressed in both AV endocardium and myocardium before and during EMT and both TGFβ2 and TGFβ3 appear to be necessary for the full morphogenetic programs of EMT in the chick (Boyer et al., 1999a; Camenisch et al., 2002; Molin et al., 2003) . These data suggest substantial interspecies differences for TGFβ signaling between the chick and the mouse in the distinct temporal events during AV EMT. Regarding BMP signaling, BMP-2 expression is restricted to the AV canal myocardium coincident with AV EMT in both the chick (Yamagishi et al., 1999; Yamada et al., 1999; Somi et al., 2004) and the mouse (Lyons et al., 1990; Sugi et al., 2004; Rivera-Feliciano and Tabin, 2006) . In our assays using chick AV explants, recombinant human noggin or dnBMPR-1B disrupted cell-cell separation, an initial step of EMT when the AV endocardial epithelium was induced by BMP-2 or associated myocardium (Figs. 2 and 5) . Furthermore, our data revealed that BMP-2 added to the AV endocardial monolayer upregulated TGFβ3 and α-SMA-expression, which are activation markers of AV EMT in the chick (Figs. 10 and 11). Therefore, consistent with our previous proposal in mice (Sugi et al., 2004) , BMP signaling in endocardial cells likely regulates activation of endocardial cells to transform them into cushion mesenchymal cells before TGFβ-signaling takes place in AV EMT in the chick. This appears to be consistent with the recent data from TGFβR2/Tie2 cre mice (Jiao et al., 2006) . Our current work using RCAS-viral gene transfer to activate or inactivate BMP receptor function in the endocardium in vitro and in vivo (ovo) has provided evidence that BMP signaling through the endocardium was essential for AV EMT in the chick. Our data further support the proposal that myocardial BMP-2 directly affects AV endocardium through a paracrine pathway that is essential for EMT and that activation of BMP receptors in endocardial cells induces AV EMT.
